{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-063253","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2025-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.591051+00:00","generated_at":"2026-05-24T04:52:33.335751+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Whitehawk completes sale of Aadi Subsidiary to Kaken for $102.4M cash","bullets":["Sale of 100% of Aadi Subsidiary, Inc. to KAKEN INVESTMENTS INC. closed on March 25, 2025.","Cash purchase price of $102.4 million after adjustments paid by Purchaser.","Pro forma financial information to be filed by amendment within four business days.","Deal previously announced on December 19, 2024 under Stock Purchase Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-063253","json":"https://secwatch.observer/filing/0001193125-25-063253.json","markdown":"https://secwatch.observer/filing/0001193125-25-063253.md","text":"https://secwatch.observer/filing/0001193125-25-063253.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312525063253/0001193125-25-063253-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312525063253/d937606d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T04:52:33.335751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"06efae7b1181f81e778eac23b8bfb0bc859d342b","claim":"Whitehawk Therapeutics, Inc. completed a disposition involving KAKEN INVESTMENTS INC. for $102.4 million (closed 2025-03-25).","evidence_excerpt":"and Aadi Subsidiary, Inc. on December 19, 2024. In accordance with the Purchase Agreement, upon the closing of the Divestiture, Purchaser paid to the Company a cash payment of $102.4 million (following applicable purchase price adjustments under the Purchase Agreement). The foregoing description of the Divestiture and the Purchase Agreement does not purport to be","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422142/000119312525063253/0001193125-25-063253-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"KAKEN INVESTMENTS INC."},{"label":"Consideration","value":"$102.4 million"},{"label":"Closing","value":"2025-03-25"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}